In accordance with these findings, we show that osseointegration did not differ between LepR−/− and LepR+/+ animals, suggesting that these conflicting clinical outcomes might be related to discreet effects of hyperglycaemia and obesity on bone healing around metal implants. The gene discussed is LEPR; the disease is Hyperglycemia.